Publications 2009
141.
Mischak-Weissinger EM, Metzger J, Krons A, Kontsendorn J, Hertenstein B, Stadler M, Holler E, Ganser A.
Prospective Evaluation of Proteomic Screening with an aGvHD-Specific Proteomic Pattern MS-17.
Blood 2009, 114(22):2246.
140.
Chen Y-C, Mühlen CVZ, Schiffer E, Christine S, Smith B, Mischak H, Peter K.
Urine Polypeptide Patterns Allow Diagnosis of Coronary Artery Disease
Heart, Lung and Circulation 2009, 18(Suppl3):S308.
139.
Zürbig P, Mischak H, Conrads S
Urinary proteome analysis for early diagnosis of diabetes and its complications
Diabetes Stoffw Herz 2009; 18: 483-494
Request
Reprint
138.
Weissinger EM, Zürbig P, Ganser A.
Proteomics studies after hematopoietic stem cell transplantation
Methods Mol Biol. 2009;506:437-52
View
Abstract Request
Reprint
137.
Zürbig P, Schiffer E, Mischak H.
Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery
Methods Mol Biol. 2009, 564:105-21
View
Abstract Request
Reprint
136.
Schiffer E, Vlahou A, Petrolekas A, Stravodimos K, Tauber R, Geschwend JE, Neuhaus J, Stolzenburg JU, Conaway MR, Mischak H, Theodorescu D
Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics
Clin Cancer Res. 2009, 15(15):4935-43.
View
Abstract Request
Reprint
135.
Dhillona AS, Yipa YY, Grindlay GJ, Pakaya JL, Dangers M, Hillmann M, Clark W, Pitte A, Mischak H, Kolch W
The C-terminus of RAF-1 acts as a 14-3-3-dependent activation switch
Cell Signal 2009, 21(11):1645-51.
View Abstract Request
Reprint
134.
Jankowski V, Giet M, Mischak H, Morgan M, Zidekm W, Jankowski J
Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system
British Journal of Pharmacology 2009, 157(7):1142-53.
View
Abstract Request
Reprint
133.
Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra JP, Dominiczak AF.
Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments
Mass Spectrom Rev. 2009, 28(5):703-24.
132.
von zur Muehlen C, Schiffer E, Zuerbig P, Mischak H, Bode C, Peter K.
P159: Urine Proteome Patterns Can Identify Atherosclerosis and in Particular Coronary Artery Disease.
Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29(7):E39.
131.
Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, Theodorescu D, Dakna M, Coon J, Mischak H
Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in ANCA associated Vasculitis
Mol Cell Proteomics 2009, 8(10):2296-307.
View
Abstract Request
Reprint
130.
Mischak H, Espandiari P, Sadrieh N, Hanig J
Profiling of rat urinary proteomic patterns associated with drug-induced nephrotoxicity using capillary electrophoresis coupled with mass spectrometry as a potential model for detection of drug-induced adverse effects
PROTEOMICS - Clinical Applications 2009, 9:1062-1071.
View
Abstract Request
Reprint
129.
Kistler A, Mischak H, Poster D, Dakna M, Wuthrich R, Serra A
Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease
Kidney Int. 2009, 76(1):89-96
View
Abstract Request
Reprint
128.
Weissinger EM, Mischak H, Kontsendorn J, Hahn A, Hahn N, Morgan M, Ganser A
Proteome analysis in hematology using capillary electrophoresis coupled on-line to mass spectrometry
Mini Rev Med Chem. 2009, 9(5):627-3
View
Abstract Request
Reprint
127.
Metzger J, Luppa PB, Good DM, Mischak H
Adapting mass spectrometry-based platforms for clinical proteomics applications: the capillary electrophoresis coupled mass spectrometry paradigm
Crit Rev Clin Lab Sci. 2009, 46(3):129-52
View
Abstract Request
Reprint
126.
Drube J, Schiffer E, Mischak H, Kemper M, Neuhaus T, Pape L, Lichtinghagen R, Ehrich JHH
Urinary proteome pattern in children with renal Fanconi syndrome
Nephrol Dial Transplant. 2009, 24(7):2161-9.
View
Abstract Request
Reprint
125.
Dakna M, He Z, Yu WC, Mischak H, Kolch W
Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment
Journal of Chromatography B 2009, 877(13): 1250-1258
View
Abstract Request
Reprint
124.
Mischak H, Massy ZA, Jankowski J
Proteomics and uremia and renal disease
Seminars in Dialysis 2009, 22(4):409-16.
View
Abstract Request
Reprint
123.
Schiffer E, Mischak H, Zimmerli LU
Proteomics in gerontology - current applications and future aspects
Gerontology 2009, 55(2):123-37.
View
Abstract Request
Reprint
122.
Muhlen C, Schiffer E, Zuerbig P, Kellmann M, Brasse M, Meert N, Vanholder RC, Dominiczak AF, Chen YC, Mischak H, Bode C, Peter K
Evaluation of Urine Proteome Pattern Analysis for Its Potential To Reflect Coronary Artery Atherosclerosis in Symptomatic Patients
Journal of Proteome Research 2009, 8(1): 335-345
View
Abstract Request
Reprint
121.
Snell-Bergeon JK, Maahs DM, Ogden LG, Kinney GL, Hokanson JE, Schiffer E, Mischak H, Rewers M
Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease
Diabetes, Technology and Therapeutics 2009, 11(1):1-9
View
Abstract Request
Reprint
120.
Harris K, Girolami M, Mischak H.
Definition of valid proteomic biomarkers: a Bayesian solution
Lecture Notes in Computer Science 2009, 5780, pp. 137–149.
119.
Zürbig P, Schiffer E, Mischak H.
Capillary Electrophoresis Coupled to Mass Spectrometry for Urinary Proteome Analysis.
Renal and Urinary Proteomics: Methods and Protocols.
Methods in Molecular Biology
2009, Editor:
Thongboonkerd V, pp.
321–332.
118.
Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra J, Dominiczak AF
Capillary electrophoresis–mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments
Anal Bioanal Chem. 2009, 393(5):1431-42.
View
Abstract Request
Reprint
117.
Mischak H, Massy ZA, Jankowski J.
PROGRESS IN UREMIC TOXIN RESEARCH: Proteomics in Uremia and Renal Disease
Seminars in Dialysis 2009, 22(4): 409-416.
116.
Vanholder R, Abou‐Deif O, Argiles A, Baurmeister U, Beige J, Brouckaert P, Brunet P, Cohen G, De Deyn PP, Drüeke TB, Fliser D, Glorieux G, Herget-Rosenthal S, Hörl WH , Jankowski J, Jörres A, Massy ZA, Mischak H, Perna AF, Rodriguez-Portillo JM, Spasovski G, Stegmayr BG, Stenvinkel P, Thornalley PJ, Wanner C, Wiecek A.
PROGRESS IN UREMIC TOXIN RESEARCH: The Role of EUTox in Uremic Toxin Research
Seminars in Dialysis 2009, 22(4): 323-328.
115.
Raedler TJ, Mischak H, Jahn H, Wiedemann K.
Proteomics as a new tool for biomarker-discovery in neuropsychiatric disorders
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes 2009, Editor: M.S. Ritsner, pp. 103-111.
114.
Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C, Mischak H, Metzger J
Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease
Journal of Proteome Research 2009, 8(1): 268-281.
View
Abstract Request
Reprint
113.
Metzger J, Schanstra JP, Mischak H
Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments
Anal Bioanal Chem. 2009, 393(5):1431-42. Epub 2008 Aug 15.
View
Abstract Request
Reprint
112.
Zürbig P, Decramer S, Dakna M, Jantos J, Good DM, Coon JJ, Bandin F, Mischak H, Bascands JL, Schanstra JP.
The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease
Proteomics. 2009, 9(8):2108-17.
View
Abstract Request
Reprint
111.
Vlahou A, Allmaier G, Attwood T, Bongcam-Rudloff E, Charonis A, Frokiaer J, Mischak H, Schanstra J, Spasovski G.
2nd Combined Working Group and Management Committee Meeting of Urine and Kidney Proteomics COST Action 29-30 March 2009, Nafplio, Greece
Proteomics Clin Appl. 2009, 3(9):1017-22.
View
Abstract Request
Reprint